Camber Capital Management LP

Est. AUM

$1.07B

13F long equity, this entity only

Positions

Period

Jun 2025 (Q2)

SEC EDGAR

Jun 2025 (Q2)

#	Issuer	Class	Value	Shares	% Portfolio	Discretion
1	SPDR S&P 500 ETF TRPUT	TR UNIT	$308.9M	500000	29.00%	SOLE
2	ZIMMER BIOMET HOLDINGS INC	COM	$91.2M	1000000	8.56%	SOLE
3	BAXTER INTL INC	COM	$86.3M	2850000	8.10%	SOLE
4	HUMANA INC	COM	$73.3M	300000	6.89%	SOLE
5	CVS HEALTH CORP	COM	$72.4M	1050000	6.80%	SOLE
6	GLOBUS MED INC	CL A	$47.2M	800000	4.43%	SOLE
7	ICON PLC	SHS	$43.6M	300000	4.10%	SOLE
8	ASCENDIS PHARMA A/S	SPONSORED ADR	$43.1M	250000	4.05%	SOLE
9	MERCK & CO INC	COM	$39.6M	500000	3.72%	SOLE
10	GSK PLCCALL	SPONSORED ADR	$38.4M	1000000	3.60%	SOLE
11	PFIZER INC	COM	$36.4M	1500000	3.41%	SOLE
12	BIOMARIN PHARMACEUTICAL INC	COM	$33.0M	600000	3.10%	SOLE
13	UNITEDHEALTH GROUP INC	COM	$31.2M	100000	2.93%	SOLE
14	VIATRIS INC	COM	$24.6M	2750000	2.31%	SOLE
15	BROOKDALE SR LIVING INC	COM	$15.0M	2150000	1.40%	SOLE
16	ZIMVIE INC	COM	$15.0M	1600000	1.40%	SOLE
17	APELLIS PHARMACEUTICALS INC	COM	$14.7M	850000	1.38%	SOLE
18	MYRIAD GENETICS INC	COM	$10.6M	2000000	1.00%	SOLE
19	EVOLENT HEALTH INC	CL A	$9.6M	850000	0.90%	SOLE
20	CONCENTRA GROUP HOLDINGS PAR	COMMON STOCK	$8.2M	400000	0.77%	SOLE
21	INOGEN INC	COM	$6.9M	975000	0.64%	SOLE
22	DENALI THERAPEUTICS INC	COM	$5.6M	400000	0.53%	SOLE
23	THERAVANCE BIOPHARMA INC	COM	$5.0M	450000	0.47%	SOLE
24	ANAPTYSBIO INC	COM	$2.8M	125000	0.26%	SOLE
25	ORASURE TECHNOLOGIES INC	COM	$2.7M	900000	0.25%	SOLE

Values in USD (reported in $thousands on 13F). Source: SEC EDGAR.